Sanofi makes deal for Tamiflu rights from Roche

The deal will give Sanofi exclusive OTC rights to the flu treatment in the U.S.
July 23, 2019

Sanofi has signed a rights deal with Roche for the rights to Tamiflu in the United States.

The deal will give Sanofi exclusive  over-the-counter rights to the flu prevention treatment.

According to Sanofi's head of consumer healthcare, this move is strategic and important.

Read the Reuters report.

Sign up for our eNewsletters
Get the latest news and updates